Abstract Acne vulgaris (acne) is a chronic inflammatory disease prevalent among adolescents and adults, with significant psychological effects. The aetiology of acne is multifactorial. Several pathophysiological associations have been identified in which Propionibacterium acnes plays a major role. This bacteria primarily affects areas containing oil glands including the face, back and trunk, where it causes the formation of seborrhoea and inflammatory lesions. The treatment methods currently in place have side effects. A novel alternative method with no side effects is hence required. In this study, we report the synthesis of an exopolysaccharide (EPS)-producing bacterial-based nanoparticle as a stable biocompatible material for drug delivery. We then evaluated the effectiveness of EPS-based nanoparticle cream against P. acnes. Our results demonstrate that EPS nanoparticles have great potential as a safe and effective topical treatment for acne vulgaris and other associated infections.
EPS                 0.770767214423883^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Polystyrene           

exopolysaccharide             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Exopolysaccharide     

trunk                         0.9999188880487926^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Trunk_(anatomy)       

nanoparticles                 0.9999999999998863^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanoparticle          

Acne vulgaris                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Acne_vulgaris         

acne                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Acne_vulgaris         

pathophysiological            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pathophysiology       

Propionibacterium acnes       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Propionibacterium_acnes

biocompatible                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Biocompatibility      

stable                        0.8841142953889981^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Stable_isotope        

adolescents                   0.9999999999646434^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adolescence           

glands                        0.968659517005457^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Lymph_node            

disease                       0.9999997017679779^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disease               

infections                    0.9977857871895822^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Infection             

topical treatment             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Topical_medication    

EPS                           0.770767214423883^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Polystyrene           

lesions                       0.9999996758162367^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Lesion                

inflammatory                  0.9999999999770353^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Inflammation          

side effects                  0.9999673899260482^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adverse_effect        

drug delivery                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Drug_delivery         

multifactorial                0.9999999129188419^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Quantitative_trait_locus

nanoparticle                  0.9999999999414513^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanoparticle          

seborrhoea                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Sebaceous_gland       

nanoparticle                  0.9999999999414513^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanoparticle          

side effects                  0.9999673899260482^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adverse_effect        

bacteria                      0.9999999999994316^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Bacteria              

acne                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Acne_vulgaris         

inflammatory                  0.9999999999770353^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Inflammation          

chronic                       0.9999998435104211^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Chronic_(medicine)    

aetiology                     0.9999999986235935^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Etiology              

acne vulgaris                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Acne_vulgaris         

cream                         0.9999999998772182^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cream_(pharmaceutical)

